Exploiting Oncogenic Drivers along the
CCNG1
Pathway for Cancer Therapy and Gene Therapy
Mol Ther Oncolytics
.
2018 Dec 12:11:122-126.
doi: 10.1016/j.omto.2018.11.002.
eCollection 2018 Dec 21.
Authors
Ahmad Al-Shihabi
1
,
Sant P Chawla
1
,
Frederick L Hall
2
,
Erlinda M Gordon
1
2
3
Affiliations
1
The Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA 90403, USA.
2
Delta Next-Gene, LLC, Santa Monica, CA 90403, USA.
3
Aveni Foundation, Santa Monica CA 90403, USA.
PMID:
30581985
PMCID:
PMC6292824
DOI:
10.1016/j.omto.2018.11.002
No abstract available
Publication types
Review